References
- Dickhaut K, Hoepner S, Eckhard J et al. Enhancement of tumour-specific immune responses in vivo by ‘MHC loading-enhancer’ (MLE). PLoS One4(9), e6811 (2009).
- Rabinowitz JD, Vrljic M, Kasson PM et al. Formation of a highly peptide-receptive state of class II MHC. Immunity9(5), 699–709 (1998).
- Kropshofer H, Arndt SO, Moldenhauer G, Hammerling GJ, Vogt AB. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity6(3), 293–302 (1997).
- Busch R, Rinderknecht CH, Roh S et al. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunol. Rev.207, 242–260 (2005).
- Falk K, Lau JM, Santambrogio L et al. Ligand exchange of major histocompatibility complex class II proteins is triggered by H-bond donor groups of small molecules. J. Biol. Chem.277(4), 2709–2715 (2002).
- Hopner S, Dickhaut K, Hofstatter M et al. Small organic compounds enhance antigen loading of class II major histocompatibility complex proteins by targeting the polymorphic P1 pocket. J. Biol. Chem.281(50), 38535–38542 (2006).
- Marin-Esteban V, Falk K, Rotzschke O. Small-molecular compounds enhance the loading of APC with encephalitogenic MBP protein. J. Autoimmun.20(1), 63–69 (2003).
- Call MJ, Xing X, Cuny GD et al.In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange. J. Immunol.182(10), 6342–6352 (2009).
- Nicholson MJ, Moradi B, Seth NP et al. Small molecules that enhance the catalytic efficiency of HLA-DM. J. Immunol.176(7), 4208–4220 (2006).
- Gupta S, Hopner S, Rupp B et al. Anchor side chains of short peptide fragments trigger ligand-exchange of class II MHC molecules. PLoS One3(3), e1814 (2008).
- Falk K, Rotzschke O, Santambrogio L, Dorf ME, Brosnan C, Strominger JL. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: enhanced in vivo potency of encephalitogenic peptides. J. Exp. Med.191(4), 717–730 (2000).
- Marin-Esteban V, Falk K, Rotzschke O. ‘Chemical analogues’ of HLA-DM can induce a peptide-receptive state in HLA-DR molecules. J. Biol. Chem.279(49), 50684–50690 (2004).
- Avva RR, Cresswell P. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity1(9), 763–774 (1994).
- Araki K, Turner AP, Shaffer VO et al. mTOR regulates memory CD8 T-cell differentiation. Nature460(7251), 108–112 (2009).
- Fissolo N, Haag S, de Graaf KL et al. Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients. Mol. Cell. Proteomics8(9), 2090–2101 (2009).